Skip to main content
Premium Trial:

Request an Annual Quote

Congenica, Edico Genome Bundle Technology

NEW YORK (GenomeWeb) – British genomics analysis startup Congenica and San Diego-based sequencing informatics firm Edico Genome are partnering to offer their products as a technology bundle. Together, they hope to help laboratories and hospitals accelerate the movement of genomics from sequencing to diagnosis of inherited diseases.

The partnership also will help Cambridge-based Congenica expand its presence in the US.

Specifically, the two companies are combining Congenica's Sapientia genome-analysis software with Edico’s field-programmable gate array bioinformatics processor, Dragen. They expect to be able to reduce "DNA-to-diagnosis" time from months to minutes.

"By combining our complementary technologies, we aim to accelerate the clinician's ability to use genomics to diagnose a patient's disease, and make this available on a global basis," Congenica CEO Thomas Weaver said in a statement.

In January, Edico Genome inked a deal with Dell EMC to integrate the Dragen processor into a 1U Dell 4130 server for genome analysis, as well as Dell EMC's Isilon scale-out networked attached storage for genomic data storage.

In late February, Congenica announced that it raised a $10 millon Series B round of venture capital.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.